Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Loncar Cancer Immunotherapy ETF (NQ: CNCR )

11.86 +0.14 (+1.19%)
Official Closing Price Updated: 4:15 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 671
Open 11.69
Bid (Size) 11.58 (1)
Ask (Size) 18.75 (2)
Prev. Close 11.72
Today's Range 11.69 - 11.86
52wk Range 11.68 - 19.36
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. 
Via InvestorPlace
5 Top-Ranked ETFs To Buy At Bargain Prices For 2023
Here are five ETFs from different zones that have plunged the most over the past year but are poised to outperform when the market resumes its uptrend. 
Via Talk Markets

Performance

YTD
-12.73%
-12.73%
1 Month
-13.18%
-13.18%
3 Month
-10.15%
-10.15%
6 Month
-15.65%
-15.65%
1 Year
-34.26%
-34.26%

More News

Read More
5 ETFs Riding High On The Biotech Comeback
Via Talk Markets
3 Promising Oncology Stocks To Consider Adding To Your Portfolio
Via Talk Markets
Best Biotech Stocks & ETFs for mRNA, Gene Editing
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.